Laurus Labs Limited — Others, 31-12-2024: ESOP/ESOS/ESPS

The Nomination & Remuneration Committee of Laurus Labs has allotted a total of 93,177 equity shares following the exercise of employee stock options, comprising 71,498 shares under the 2018 Scheme (Grant-II) at ₹356 each, 20,429 shares under the 2016 Scheme (Grant-III) at ₹350 each, and 1,250 shares under the 2018 Scheme (Grant-III) at ₹350 each. After these allotments, the paid-up capital reaches ₹107.85 crore.

This move reflects the company's commitment to incentivizing employees, which may enhance morale and retain talent. Investors might view this as a positive outlook, signaling management's focus on growth and engagement.